Mark Catherwood

3.0k total citations
53 papers, 1.3k citations indexed

About

Mark Catherwood is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Mark Catherwood has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 21 papers in Pathology and Forensic Medicine and 17 papers in Molecular Biology. Recurrent topics in Mark Catherwood's work include Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Mark Catherwood is often cited by papers focused on Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Mark Catherwood collaborates with scholars based in United Kingdom, Ireland and Netherlands. Mark Catherwood's co-authors include H. Denis Alexander, Christine Matthews, P.C. Sharpe, Dorothy McMaster, Lesley Powell, Elisabeth R. Trimble, Paul Anderson, Ken Mills, T. C. M. Morris and Manuel Salto‐Tellez and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Mark Catherwood

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Catherwood United Kingdom 21 444 433 385 287 225 53 1.3k
Annemieke Kuil Netherlands 19 617 1.4× 565 1.3× 437 1.1× 1.4k 4.8× 322 1.4× 23 2.4k
Ken Ohmine Japan 21 605 1.4× 210 0.5× 110 0.3× 528 1.8× 119 0.5× 82 1.4k
Swamy Yeleswaram United States 21 461 1.0× 433 1.0× 140 0.4× 447 1.6× 369 1.6× 65 1.7k
Yasuhide Ikenaka Japan 27 896 2.0× 189 0.4× 271 0.7× 370 1.3× 158 0.7× 55 2.9k
Eunju Hurh United States 20 990 2.2× 210 0.5× 121 0.3× 210 0.7× 171 0.8× 43 2.2k
Junichi Yoshii Japan 25 915 2.1× 179 0.4× 257 0.7× 361 1.3× 153 0.7× 42 2.7k
Mirko Doni Italy 19 1.2k 2.6× 93 0.2× 159 0.4× 445 1.6× 148 0.7× 29 1.7k
Tetsuro Sano Japan 19 706 1.6× 124 0.3× 118 0.3× 275 1.0× 216 1.0× 49 1.4k
Andrew E. Place United States 16 862 1.9× 122 0.3× 103 0.3× 472 1.6× 170 0.8× 55 1.6k
Qiang Wen China 19 493 1.1× 203 0.5× 67 0.2× 230 0.8× 92 0.4× 61 1.1k

Countries citing papers authored by Mark Catherwood

Since Specialization
Citations

This map shows the geographic impact of Mark Catherwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Catherwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Catherwood more than expected).

Fields of papers citing papers by Mark Catherwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Catherwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Catherwood. The network helps show where Mark Catherwood may publish in the future.

Co-authorship network of co-authors of Mark Catherwood

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Catherwood. A scholar is included among the top collaborators of Mark Catherwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Catherwood. Mark Catherwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaur, Harsimar, Lawrence Hsu Lin, David L. Kolin, et al.. (2025). Primary Endometrial Gastric (Gastrointestinal)-type Mucinous Adenocarcinoma. The American Journal of Surgical Pathology. 49(6). 564–577. 3 indexed citations
2.
Malčíková, Jitka, Šárka Pavlová, Panagiotis Baliakas, et al.. (2024). ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update. Leukemia. 38(7). 1455–1468. 8 indexed citations
3.
Catherwood, Mark, et al.. (2024). Initiation of molecular testing of endometrial carcinomas in a population‐based setting: practical considerations and pitfalls. Histopathology. 86(4). 611–626. 3 indexed citations
4.
Brown, R, Andrew Hindley, R Cuthbert, et al.. (2024). Association between JAK2V617F variable allele frequency and risk of thrombotic events in patients with myeloproliferative neoplasms. Irish Journal of Medical Science (1971 -). 193(6). 2883–2888. 2 indexed citations
5.
Hindley, Andrew, et al.. (2020). Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort. Journal of Clinical Pathology. 74(12). 808–811. 12 indexed citations
6.
Houghton, Oisín, Peter Stewart, Chang H. Kim, et al.. (2020). A novel next generation sequencing approach to improve sarcoma diagnosis. Modern Pathology. 33(7). 1350–1359. 19 indexed citations
7.
Catherwood, Mark, David González, David Donaldson, et al.. (2019). Relevance of TP53 for CLL diagnostics. Journal of Clinical Pathology. 72(5). 343–346. 11 indexed citations
8.
Hennessy, Bryan T., David Swan, Nadine J. Barrett, et al.. (2019). PF493 TP53 STATUS IN MANTLE CELL LYMPHOMA (MCL) ‐ A 10 YEAR SINGLE CENTER EXPERIENCE. HemaSphere. 3(S1). 199–199.
9.
Cosimo, Emilio, Anuradha Tarafdar, Mark Catherwood, et al.. (2018). AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival. Clinical Cancer Research. 25(5). 1574–1587. 23 indexed citations
10.
11.
McArt, Darragh G., Ken Mills, Mark Catherwood, et al.. (2013). Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis. PLoS ONE. 8(7). e69604–e69604. 85 indexed citations
12.
Natoni, Alessandro, Laura S. Murillo, Mark Catherwood, et al.. (2011). Mechanisms of Action of a Dual Cdc7/Cdk9 Kinase Inhibitor against Quiescent and Proliferating CLL Cells. Molecular Cancer Therapeutics. 10(9). 1624–1634. 37 indexed citations
13.
Catherwood, Mark, et al.. (2010). Multidrug resistance in the chronic lymphoproliferative disorders. Leukemia & lymphoma. 51(10). 1793–1804. 8 indexed citations
14.
Greene, Lisa M., Siobhan McGuckin, Paul Browne, et al.. (2009). The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia. Cancer Research. 69(21). 8366–8375. 30 indexed citations
15.
Catherwood, Mark, et al.. (2009). Myeloid sarcoma of the small bowel associated with a CBFβ/MYH11 fusion and inv(16)(p13q22): a case report. Journal of Clinical Pathology. 62(8). 757–759. 13 indexed citations
16.
Catherwood, Mark, Nick Orr, Leeona Galligan, et al.. (2009). ABCB1 (MDR1)rs1045642 is associated with increased overall survival in plasma cell myeloma. Leukemia & lymphoma. 50(4). 566–570. 23 indexed citations
17.
Catherwood, Mark, et al.. (2006). Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin’s lymphomas with high rates of somatic hypermutation. Journal of Clinical Pathology. 60(5). 524–528. 23 indexed citations
18.
Catherwood, Mark, H. Denis Alexander, Damian McManus, R Cuthbert, & T. C. M. Morris. (2003). Immunoglobulin Gene Rearrangement Investigations in the Diagnosis of Lymphoid Malignancies from Formaldehyde-fixed Biopsies. Leukemia & lymphoma. 44(4). 645–648. 8 indexed citations
19.
Catherwood, Mark, Lesley Powell, Paul Anderson, et al.. (2002). Glucose-induced oxidative stress in mesangial cells. Kidney International. 61(2). 599–608. 149 indexed citations
20.
Sharpe, P.C., Kevin K.M. Yue, Mark Catherwood, Dorothy McMaster, & E.R. Trimble. (1998). The effects of glucose-induced oxidative stress on growth and extracellular matrix gene expression of vascular smooth muscle cells. Diabetologia. 41(10). 1210–1219. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annemieke Kuil Breakdown of academic impact, for papers by Ken Ohmine Breakdown of academic impact, for papers by Swamy Yeleswaram Breakdown of academic impact, for papers by Yasuhide Ikenaka Breakdown of academic impact, for papers by Eunju Hurh Breakdown of academic impact, for papers by Junichi Yoshii Breakdown of academic impact, for papers by Mirko Doni Breakdown of academic impact, for papers by Tetsuro Sano Breakdown of academic impact, for papers by Andrew E. Place Breakdown of academic impact, for papers by Qiang Wen
Rankless by CCL
2026